Trial record 1 of 1 for:
SCO101-001
A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04247256 |
|
Recruitment Status : Unknown
Verified December 2021 by Scandion Oncology A/S.
Recruitment status was: Recruiting
First Posted : January 30, 2020
Last Update Posted : March 2, 2022
|
Sponsor:
Scandion Oncology A/S
Collaborator:
TFS Trial Form Support
Information provided by (Responsible Party):
Scandion Oncology A/S
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | June 30, 2022 |
| Estimated Study Completion Date : | June 30, 2022 |